Yajie Sun

8PUBLICATIONS
46CO-AUTHORS
Medical infection agents (incl. prions)Radiation therapyInnate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 07, 2026
Chemoradiotherapy-Integrated Tumor Cell-Derived Microparticles Mediate Tumor Eradication in Malignant Pleural Effusion.

Minqi Zhou, Lingyi Kong, Weidong Zhong

|Jan 09, 2026
Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Mediates Antitumor Immune Evasion.

Lingyi Kong, Minqi Zhou, Wenqian Yuan

|Mar 04, 2025
Macrophage-Derived Itaconate Suppresses Dendritic Cell Function to Promote Acquired Resistance to Anti-PD-1 Immunotherapy.

Xiao Yang, Yue Deng, Ying Ye

|Oct 23, 2024
A self-assembled, genetically engineered, irradiated tumor cell debris vaccine.

Yajie Sun, Yan Hu, Yuanyuan Geng

|Aug 06, 2024
53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer.

Yajie Sun, Jeffrey Patterson-Fortin, Sen Han

|Jan 29, 2024
Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis.

Bin Zhang, Jie Li, Yijun Wang

Pageof 2

Frequent Collaborators

4 joint publications

Kunyu Yang

3 joint publications

Chao Wan

3 joint publications

Jingshu Meng

3 joint publications

Honglin Jin